China Deal Review: Unfazed by regulatory action, PE-VC funding rises 11.6% to $7b in July

China Deal Review: Unfazed by regulatory action, PE-VC funding rises 11.6% to $7b in July

Hong Kong. Photo by Ruslan Bardash on Unsplash

27 August, 2021

Banma biotech ESWIN Material medical devices Sequoia Capital China SVOLT Energy Technology

Printed by Unregistered user on Mon, 21 Jul 2025 18:15:57 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Deal Review: Investors pump over $6.2b into startups in June, up 22.8% from May

China VC investment in Southeast Asia drops substantially in H1

Read more from Greater China

SenseTime spin-off AI chipmaker Sunrise bags over $139m in new round

China’s humanoid robot maker EngineAI snaps over $139m in fresh funding